GCM KOREA

行业

生态与监测, 食品配料, 水务

主题

污水、水处理与生物修复, 微藻（螺旋藻、小球藻、裸藻）

角色

设备 — “…such as the semiconductor equipment manufacturer (주)GCM Korea or the ASX-listed GCM Corporation [4][5][6]. <de…”

为何属于生物经济

GCM KOREA是一家环境服务公司，开发以天然矿物为基础的水处理剂，用于河流、湖泊和海洋的净化。

发现途径

[Rubric] South Korea · growing-media

尚未被列为已评级方案的供应商。

• 2026-09-10 GC Biopharma Enters Phase 2 for Homegrown mRNA Vaccine, Targets 2028 Rollout - Seoul Economic Daily
  GC Biopharma Korea (GCM Korea) is advancing domestic vaccine self-sufficiency by 2028, entering Phase 2 of a COVID-19 mRNA vaccine trial (GC4006A) and planning a Phase 3 IND in 2027, using its in-house mRNA-LNP platform to expand into oncology and rare genetic …
• 2026-08-10 GCMediAI Reports First-Half Operating Profit of 6.2 Billion Won, Up 302% Year-Over-Year - EDAILY
  GCMediAI (GCM KOREA) reports strong first-half results with 101.4 billion won in revenue and 6.2 billion won in operating profit, up 7.9% and 302% year-over-year, driven by acquisition effects and profitability improvements across subsidiaries. The company is …
• 2025-07-10 We’re pleased to announce that MGM O'Connor Corporate Advisory (MGMOCA) has signed an official partnership with Green Critical Minerals Ltd (ASX:GCM), as revealed in GCM’s ASX announcement today, to spearhead their VHD …
  GCM Korea is being driven as a key market entry hub for Green Critical Minerals’ very high density (VHD) graphite, with MGMOCA partnering to secure high-value engagements and showcase scalable VHD graphite thermal-management solutions in Korea, aiming for …
• 2026-10-01 GC녹십자, 독감 NIP부터 mRNA까지…백신 자급화 기여 확대 < 제약·바이오 < 파마시안 < 기사본문 - 메디파나뉴스
  GC녹십자(GC Korea) is expanding domestic vaccine self-sufficiency by supplying the largest share of flu vaccines for Korea’s National Immunization Program and advancing in-house vaccine development, including a COVID-19 mRNA candidate (GC4006A) and …
• 2026-03-17 USDA seeking public input on expanding sweet potato imports from South Korea - Gulf Coast Media
  The article reports that USDA APHIS is seeking public comment on expanding the import of fresh Korean sweet potatoes to all U.S. states, beyond current restrictions to Guam and the CNMI, with safety measures in place; a 60-day comment period ends May 12. It …
• 2026-09-21 GC녹십자, NIP 사용 '지씨플루' 국가출하승인 획득 < 제약·바이오 < 파마시안 < 기사본문 - 메디파나뉴스
  GC녹십자 (GC Korea) has begun domestic shipments of its 4가 influenza vaccine, GC流 Quadri-valent Pre-filled Syringe, for the National Immunization Program (NIP) this year, with plans to supply about 1.74 million doses. The company also has 대한 코박스플루4가PF주 approved …

同类企业

SK Telecom · SK Group · Maxis · LG유플러스 (LG Uplus) · AIS · NTT DOCOMO · NETS · LINE